Literature DB >> 13773272

Active immunization of mice against Candida albicans.

S MOURAD, L FRIEDMAN.   

Abstract

Entities:  

Keywords:  MONILIASIS/immunology

Mesh：

Year:  1961        PMID： 13773272     DOI： 10.3181/00379727-106-26405

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  14 in total

1.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

3.  Decontamination of gnotobiotic mice experimentally monoassociated with Candida albicans.

Authors:  M Wagner; K K Srivastava
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

4.  Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

Authors:  W M Scheld; R A Calderone; J P Brodeur; M A Sande
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

5.  Variable assimilation of carbon compounds by Candida albicans.

Authors:  R E Syverson
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

6.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

7.  Growth and invasiveness of Candida albicans in the germ-free and conventional mouse after oral challenge.

Authors:  A W Phillips; E Balish
Journal:  Appl Microbiol       Date:  1966-09

8.  Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.

Authors:  R Levy; E Segal; E Eylan
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Production in mice of tolerance to the toxic manifestations of Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

10.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.